CPIX Cumberland Pharmaceuticals

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc.

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky announces it has commenced an investigation Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) concerning possible breaches of fiduciary duty. To obtain additional information, go to:

http://zlk.9nl.com/cumberland-pharmaceuticals-cpix

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
17/03/2017

Underlying

CPIXCumberland Pharmaceuticals

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cumberland Pharmaceuticals

MarketLine Department
  • MarketLine Department
EUR 298.10
BAYN BAYER AG
CPIX Cumberland Phar... ... (+4)

Salix Pharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnershi...

Summary Marketline's Salix Pharmaceuticals, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Salix Pharmaceuticals, Ltd. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakd...

BAYN BAYER AG
CPIX CUMBERLAND PHARMACEUTICALS
GSK GLAXOSMITHKLINE PLC
SHP SHIRE PLC (INACTIVE)
10/29/20 October 29, 2020 173 EN
Free Trial
CPIX Cumberland Phar...

1 director sold

A director at Cumberland Pharmaceuticals Inc sold 11,570 shares at 5.295USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...

CPIX CUMBERLAND PHARMACEUTICALS
09/27/19 September 27, 2019 1 EN
 PRESS RELEASE
Free
CPIX Cumberland Phar...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Co...

NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) concerning possible breaches of fiduciary duty. To obtain additional information, go to: http://zlk.9nl.com/cumberland-pharmaceuticals-cpix or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you. Levi & Korsinsky is a national firm with offices in New York,...

March 17, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch